VVOS

Vivos Therapeutics Inc

Sep 17 • 01:06PM ET

3.47

+0.07 1.99 %

Healthcare • Medical Devices • USA • NASD

Peers: ALGN XRAY NVST HSIC PDCO STAA SMLR ZYXI GMED MMSI

Index	-	P/E	-	EPS (ttm)	-1.88	Insider Own	45.79%	Shs Outstand	7.32M	Perf Week	-8.99%
Market Cap	26.03M	Forward P/E	-	EPS next Y	-1.34	Insider Trans	0.00%	Shs Float	4.07M	Perf Month	-22.08%
Enterprise Value	33.21M	PEG	-	EPS next Q	-0.49	Inst Own	5.39%	Short Float	4.77%	Perf Quarter	60.53%
Income	-14.32M	P/S	1.81	EPS this Y	11.49%	Inst Trans	15.42%	Short Ratio	0.26	Perf Half Y	-2.32%
Sales	14.39M	P/B	5.54	EPS next Y	31.55%	ROA	-68.39%	Short Interest	0.19M	Perf YTD	-19.17%
Book/sh	0.63	P/C	5.92	EPS next 5Y	-	ROE	-262.03%	52W High	7.95 -56.38%	Perf Year	17.54%
Cash/sh	0.59	P/FCF	-	EPS past 3/5Y	54.71% 32.77%	ROIC	-93.61%	52W Low	1.98 75.13%	Perf 3Y	-87.94%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-3.80% 5.70%	Gross Margin	50.56%	Volatility	5.99% 10.07%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2.31	EPS Y/Y TTM	70.21%	Oper. Margin	-98.89%	ATR (14)	0.39	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.05	Sales Y/Y TTM	2.65%	Profit Margin	-99.49%	RSI (14)	36.40	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.05	EPS Q/Q	7.73%	SMA20	-15.38%	Beta	6.95	Target Price	5.25
Payout	-	Debt/Eq	2.53	Sales Q/Q	-5.77%	SMA50	-27.09%	Rel Volume	11.84	Prev Close	3.40
Employees	109	LT Debt/Eq	2.34	Earnings	Aug 19 AMC	SMA200	-7.94%	Avg Volume	750.92K	Price	3.47
IPO	Dec 11, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	-44.74% 13.54%	Trades		Volume	5,122,763	Change	1.99%

Today 08:30AM	Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment (GlobeNewswire)
Aug-20-25 03:06AM	Vivos Therapeutics Inc (VVOS) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Aug-19-25 04:20PM	Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update (GlobeNewswire)
08:30AM	Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call (GlobeNewswire)
Aug-12-25 05:15PM	Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
08:03AM	Loading…
Aug-07-25 08:03AM	Vivos Calls Out Medical Blind Spot: OSA's Overlooked Dangerous Symptoms (PR Newswire)
Jul-30-25 08:45AM	Vivos Therapeutics Adds to Management Team to Support Expansion and Growth (GlobeNewswire)
08:10AM	Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Beat Estimates (Zacks)
Jul-22-25 08:42AM	Ignored and Undiagnosed: Sleep Apnea Threatens Women's Cognitive Health (PR Newswire)
Jul-10-25 08:02AM	CPAP Is Failing Patients With OCD--Vivos Exposes the Hidden Mental Health Risk (PR Newswire) +11.17%
Jul-01-25 08:30AM	Vivos Therapeutics Receives Medicare Approval for VidaSleep Oral Appliance (GlobeNewswire) +22.47%
Jun-26-25 08:30AM	New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children (GlobeNewswire) +10.49%
Jun-11-25 08:30AM	Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada (GlobeNewswire) +5.21%
May-16-25 01:00PM	Vivos Therapeutics Inc (VVOS) Q1 2025 Earnings Call Highlights: Strategic Acquisitions and FDA ... (GuruFocus.com) -16.99%
May-15-25 06:00PM	Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:20PM	Loading…
04:20PM	Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update (GlobeNewswire)
May-14-25 09:15AM	Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call (GlobeNewswire)
May-08-25 06:25PM	Nektar Therapeutics (NKTR) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +5.63%
May-06-25 10:00AM	Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Apr-16-25 08:30AM	Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada (GlobeNewswire) -5.02%
Apr-02-25 09:01PM	Vivos Therapeutics Inc (VVOS) Q4 2024 Earnings Call Highlights: Strategic Shifts Propel Revenue ... (GuruFocus.com)
Apr-01-25 12:18AM	Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript (Seeking Alpha) -7.72%
Mar-31-25 06:55PM	Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates (Zacks) -8.36%
04:20PM	Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Mar-28-25 08:30AM	Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call (GlobeNewswire)
Mar-26-25 05:15PM	Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates (Zacks) -8.31%
Mar-20-25 05:15PM	VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
Feb-24-25 08:30AM	Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide (GlobeNewswire) +10.90%
Feb-18-25 08:30AM	Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET. (GlobeNewswire) -11.50%
Dec-23-24 08:00AM	Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
12:00PM	Loading…
Dec-18-24 12:00PM	All You Need to Know About Vivos Therapeutics (VVOS) Rating Upgrade to Buy (Zacks) -7.35%
Nov-15-24 04:00AM	Vivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com) -8.97%
Nov-14-24 04:05PM	Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-13-24 05:00PM	Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Oct-08-24 07:30AM	Vivos Therapeutics Granted CPT Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association (GlobeNewswire)
Sep-19-24 07:00AM	Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -22.03%
Sep-18-24 10:05AM	Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children (Benzinga) +47.50%
07:00AM	Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring (GlobeNewswire)
Aug-14-24 04:05PM	Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire) -5.11%
07:30AM	Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Jul-01-24 12:33PM	Vivos eyes human trials for radiation treatment gel with IDE submission (Clinical Trials Arena) +6.31%
Jun-27-24 07:30AM	Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model (GlobeNewswire) +9.63%
Jun-12-24 07:30AM	Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance (GlobeNewswire) -8.24%
May-20-24 01:04PM	Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote FOR Re-Election of Its Highly Qualified Directors (GlobeNewswire)
May-15-24 01:01PM	Vivos Therapeutics Inc (VVOS) Q1 2024 Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com) -12.45%
07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-14-24 04:05PM	Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire) +23.88%
07:30AM	Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Apr-09-24 02:45PM	Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices (News Direct) -9.08%
08:53AM	Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today? (InvestorPlace)
07:30AM	Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement (GlobeNewswire)
Apr-01-24 12:53PM	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.23%
Mar-28-24 08:53PM	VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:05PM	Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update (GlobeNewswire)
07:30AM	Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call (GlobeNewswire)
Feb-22-24 12:39PM	3 Stocks to Turn $1,000 Into $1 Million: February 2024 (InvestorPlace)
Feb-15-24 08:00AM	Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds (GlobeNewswire) +6.14%
Feb-12-24 09:24AM	Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions (News Direct)
Feb-06-24 07:30AM	Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities (GlobeNewswire)
Jan-08-24 07:30AM	Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA (GlobeNewswire)
Dec-11-23 07:30AM	Vivos Therapeutics Presents Groundbreaking Event: Empowering Women to Champion Airway (GlobeNewswire) -14.44%
Nov-30-23 08:51AM	Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today? (InvestorPlace) -40.24%
01:20AM	Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea (MedTech Dive)
Nov-29-23 01:04PM	Vivos Therapeutics hits major milestone with FDA clearance for treating severe sleep apnea (News Direct) +833.94%
11:56AM	Why Is Vivos Therapeutics (VVOS) Stock Up 290% Today? (InvestorPlace)
08:07AM	UPDATE 2-US FDA clears Vivos Therapeutics' oral device for sleep apnea (Reuters)
07:39AM	US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea (Reuters)
07:30AM	Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea (GlobeNewswire)
Nov-14-23 04:05PM	Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +9.71%
Nov-09-23 04:30PM	Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call (GlobeNewswire) -11.55% -5.84%
Nov-03-23 01:51PM	Vivos Therapeutics agrees to nationwide distribution deal with in-home respiratory dealer Lincare (News Direct) -5.52%
Nov-02-23 05:00PM	Vivos Therapeutics Closes $4 Million Private Placement (GlobeNewswire) +7.10%
Oct-31-23 08:00AM	Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -16.19%
Oct-26-23 07:30AM	Vivos Therapeutics Announces Reverse Stock Split (GlobeNewswire) -6.90%
Oct-24-23 07:30AM	Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare (GlobeNewswire) -5.76%
Oct-12-23 08:50AM	Here Is Why Bargain Hunters Would Love Fast-paced Mover Vivos Therapeutics, Inc. (VVOS) (Zacks)
Oct-11-23 01:47PM	Vivos Therapeutics secures Middle East-North Africa distribution deal and Stanford study (News Direct)
07:30AM	Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine (GlobeNewswire)
Oct-05-23 07:30AM	Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion (GlobeNewswire) +6.90%
Oct-04-23 07:30AM	Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark Clear Aligners to Its National Network of Providers (GlobeNewswire) +64.59%
Oct-02-23 07:30AM	New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference (GlobeNewswire)
Aug-23-23 09:55AM	Here's Why Vivos Therapeutics, Inc. (VVOS) Could be Great Choice for a Bottom Fisher (Zacks)
Aug-16-23 04:05PM	Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire) +5.12% -7.05%
07:30AM	Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Aug-14-23 05:06PM	Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Aug-10-23 08:31PM	Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call (GlobeNewswire) +9.97%
Jun-15-23 12:55PM	Vivos Therapeutics highlights 1Q financial and operational growth with major acquisition (News Direct) +15.77%
Jun-13-23 08:50AM	Looking for a Fast-paced Momentum Stock at a Bargain? Consider Vivos Therapeutics, Inc. (VVOS) (Zacks) +14.55%
Jun-10-23 04:31PM	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q1 2023 Earnings Call Transcript (Insider Monkey)
Jun-09-23 01:04PM	Q1 2023 Vivos Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -10.17%
Jun-08-23 05:25PM	Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +13.25%
04:05PM	Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Jun-06-23 04:30PM	Vivos Therapeutics Schedules Release of First Quarter 2023 Financial Results and Conference Call (GlobeNewswire)
May-16-23 01:19PM	Vivos Therapeutics talks clinical study success of POD migraine treatment, new timeline for cashflow (News Direct) +9.09%
May-09-23 07:30AM	Vivos Therapeutics Announces Additional Strategic Initiatives Aimed at Accelerating Anticipated Timeline for Cash Flow Positive Operations (GlobeNewswire)
May-01-23 04:09PM	A Headache-Free Future? Vivos' POD Device Slashes Migraine Symptoms by 89% in Clinical Study (Benzinga)
07:30AM	Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos POD® Appliance Treatment (GlobeNewswire)
Apr-05-23 06:36AM	The Vivos Therapeutics, Inc. (NASDAQ:VVOS) Analyst Just Cut Their Revenue Forecast By 14% (Simply Wall St.)
Apr-04-23 12:30PM	Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-30-23 04:05PM	Vivos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Operational Update (GlobeNewswire) +8.99% -5.25%

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VVOS

Vivos Therapeutics Inc

Upgrade your FINVIZ experience